Clinical trial

Rheumatoid Arthritis Treatment and Biopsy Study Assessing Certolizumab Pegol (Cimzia)

NCT01374971

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2011-09-01

PhasePHASE3

Study timeline

Study start (unknown)2011-09-01Date precision: month

Registry last updated2014-04-08

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Rheumatoid Arthritisunresolved

Interventions

Certolizumab Pegol (CZP)DRUG

Arthroscopic synovial tissue biopsyPROCEDURE

Sponsors & collaborators

Nathan Wei, MD, FACP, FACR:lead sponsor

University of California, San Diegocollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01374971 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.